185 related articles for article (PubMed ID: 33159487)
1. Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.
Rajendran P; Ben Ammar R; Al-Saeedi FJ; Elsayed Mohamed M; Islam M; Al-Ramadan SY
J Cell Mol Med; 2020 Dec; 24(24):14525-14538. PubMed ID: 33159487
[TBL] [Abstract][Full Text] [Related]
2. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA
Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract][Full Text] [Related]
4. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
5. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
[TBL] [Abstract][Full Text] [Related]
6. DEK-targeting aptamer DTA-64 attenuates bronchial EMT-mediated airway remodelling by suppressing TGF-β1/Smad, MAPK and PI3K signalling pathway in asthma.
Song Y; Wang Z; Jiang J; Piao Y; Li L; Xu C; Piao H; Li L; Yan G
J Cell Mol Med; 2020 Dec; 24(23):13739-13750. PubMed ID: 33124760
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
Zhu J; Wen K
Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
[TBL] [Abstract][Full Text] [Related]
8. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma.
Yu CC; Huang SY; Chang SF; Liao KF; Chiu SC
Molecules; 2020 May; 25(10):. PubMed ID: 32466169
[TBL] [Abstract][Full Text] [Related]
9. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
[TBL] [Abstract][Full Text] [Related]
10. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.
Li W; Ma J; Ma Q; Li B; Han L; Liu J; Xu Q; Duan W; Yu S; Wang F; Wu E
Curr Med Chem; 2013; 20(33):4185-4194. PubMed ID: 23992306
[TBL] [Abstract][Full Text] [Related]
12. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
[TBL] [Abstract][Full Text] [Related]
13. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
Tsai PC; Fu YS; Chang LS; Lin SR
Toxicon; 2016 Mar; 111():108-20. PubMed ID: 26774845
[TBL] [Abstract][Full Text] [Related]
14. Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.
Prasad P; Vasas A; Hohmann J; Bishayee A; Sinha D
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708951
[TBL] [Abstract][Full Text] [Related]
15. Brusatol reverses lipopolysaccharide-induced epithelial-mesenchymal transformation and induces apoptosis through PI3K/Akt/NF-кB pathway in human gastric cancer SGC-7901 cells.
Chen H; Jiang T; Chen H; Su J; Wang X; Cao Y; Li Q
Anticancer Drugs; 2021 Apr; 32(4):394-404. PubMed ID: 33229902
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis.
Iskender B; Izgi K; Canatan H
Mol Cell Biochem; 2016 May; 416(1-2):71-84. PubMed ID: 27032769
[TBL] [Abstract][Full Text] [Related]
17. CD24 gene inhibition and TIMP-4 gene upregulation by Imperata cylindrica's root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT.
Nayim P; Mbaveng AT; Sanjukta M; Rikesh J; Kuete V; Sudhir K
J Ethnopharmacol; 2021 Jul; 275():114111. PubMed ID: 33848610
[TBL] [Abstract][Full Text] [Related]
18. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
[TBL] [Abstract][Full Text] [Related]
19. Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions.
Lee WT; Lee TH; Cheng CH; Chen KC; Chen YC; Lin CW
Food Chem Toxicol; 2015 Apr; 78():33-41. PubMed ID: 25656647
[TBL] [Abstract][Full Text] [Related]
20. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
